A new analysis of AstraZeneca’s cholesterol-lowering statin Crestor shows that the drug sharply reduces the risk of venous thromboembolism (VTE), a potentially fatal disorder in which blood clots can form in the legs and travel to the lungs.
A new experimental device to treat atrial fibrillation had mixed results in a recent study but still shows promise as a treatment option. The Watchman is the first device designed to permanently treat atrial fibrillation, a heart condition in which blood stagnates in a small pouch called the left atrial appendage.
Only 9 percent of U.S. hospitals use electronic medical records, according to a new survey. It’s a far cry from the comprehensive, high-tech environment supported by the Obama and Bush administrations.
Pathway Medical Technologies, Inc. recently announced that it has secured a $40 million Series D round of financing, reports DeviceSpace. Raising such a large amount of capital is a rare achievement for a medical device venture, particularly in today’s tough economic climate.
A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.
Look out, Spider-Man. A British company has reproduced the silk that spider webs are made out of, for use in repairing bone and joint injuries. Spidrex tissue scaffolds, developed by Oxford Biomaterials, work in tandem with the body’s ability to heal itself…
It sounds like something out of a sci-fi film: microscopic robots that can be injected into the bloodstream to perform surgical procedures. This futuristic concept is closer to reality than one might think. Researchers at Australia’s Monash University have created tiny surgical microbots to treat conditions including stroke and arterial blockage.
Patients who dread traditional blood tests (and the accompanying needles) may one day have reason to rejoice. San Diego device company TearLab is developing a point-of-care diagnostic test that uses tears to identify disease-indicating protein biomarkers.
Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV.
Center have created a test that could help doctors identify which breast cancer patients need aggressive therapy. The study, published in the online version of Clinical Cancer Research, could prevent many women from undergoing unnecessary chemotherapy or radiation treatment.
Copyright © 2024 | WordPress Theme by MH Themes